2022 - Research.com Microbiology in Netherlands Leader Award
Charles A. Boucher focuses on Internal medicine, Virology, Immunology, Drug resistance and Virus. Charles A. Boucher has included themes like Gastroenterology, Surgery, Oncology and Cardiology in his Internal medicine study. His Cardiology research includes elements of Preoperative care and Scintigraphy.
His Virology study integrates concerns from other disciplines, such as Mutation, Protease inhibitor, Reverse transcriptase and Protease. The concepts of his Immunology study are interwoven with issues in Asymptomatic and Acquired immunodeficiency syndrome. His Drug resistance study combines topics in areas such as HIV drug resistance, Efavirenz and Epidemiology.
Charles A. Boucher mostly deals with Internal medicine, Cardiology, Virology, Immunology and Virus. The various areas that Charles A. Boucher examines in his Internal medicine study include Gastroenterology and Surgery. His Cardiology research incorporates elements of Scintigraphy and Heart rate.
His Virology research is multidisciplinary, incorporating elements of Mutation, Reverse transcriptase and Drug resistance. His studies in Immunology integrate themes in fields like Acquired immunodeficiency syndrome and Chemotherapy. He interconnects Oseltamivir and Protease in the investigation of issues within Virus.
The scientist’s investigation covers issues in Virology, Drug resistance, Internal medicine, Immunology and Viral load. His Virology study often links to related topics such as Reverse transcriptase. His study in Drug resistance is interdisciplinary in nature, drawing from both Mutation, HIV drug resistance, Emtricitabine, Antiretroviral therapy and Genotype.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Cardiology. His Immunology study deals with Disease intersecting with Microbiome. His Viral load research focuses on Dolutegravir and how it relates to Raltegravir, Randomized controlled trial, Integrase inhibitor and Integrase.
His primary areas of investigation include Virology, Drug resistance, Viral load, Internal medicine and Immunology. He combines subjects such as Oseltamivir and Genotype with his study of Virology. His research in Drug resistance intersects with topics in Lamivudine and Efavirenz.
His Viral load research includes themes of Gastroenterology and Dolutegravir. His biological study spans a wide range of topics, including HIV drug resistance, Men who have sex with men and Reverse-transcriptase inhibitor. The study incorporates disciplines such as Young adult and Antiretroviral therapy in addition to Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir.
Molla A;Korneyeva M;Gao Q;Vasavanonda S.
Nature Medicine (1996)
Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery
K.A. Eagle;C.M. Coley;J.B. Newell;D.C. Brewster.
Annals of Internal Medicine (1989)
Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes.
PLOS ONE (2009)
Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial
J. Durant;P. Clevenbergh;P. Halfon;P. Delgiudice.
The Lancet (1999)
Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery.
C A Boucher;D C Brewster;R C Darling;R D Okada.
The New England Journal of Medicine (1985)
Technetium-99m Hexakis 2-Methoxyisobutyl Isonitrile: Human Biodistribution, Dosimetry, Safety, and Preliminary Comparison to Thallium-201 for Myocardial Perfusion Imaging
F J Wackers;D S Berman;J Maddahi;D D Watson.
The Journal of Nuclear Medicine (1989)
Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets
Vincent J. Munster;Emmie de Wit;Judith M. A. van den Brand;Sander Herfst.
Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)
Rob Schuurman;Monique Nijhuis;Remko van Leeuwen;Pauline Schipper.
The Journal of Infectious Diseases (1995)
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
N. K. Back;M. Nijhuis;W. Keulen;C. A. Boucher.
The EMBO Journal (1996)
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: